X4 Pharmaceuticals, Inc. (XFOR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -19.6M | -15.53M | -27.82M | -29.9M | -12.37M | -32.99M | -34.03M | -30.28M | -33.6M | -27.75M | -20.83M | -21.43M |
| Operating CF Margin % | -723.74% | -604.63% | -1576.32% | -1515.51% | -42.93% | -2300.91% | -6077.14% | -5377.8% | - | - | - | - |
| Operating CF Growth % | -58.47% | 52.94% | 18.25% | 1.24% | 63.19% | -18.91% | -63.4% | -41.32% | -26.72% | -45.33% | -7.88% | -15.97% |
| Net Income | -20.24M | -23.93M | -29.82M | -25.74M | 282K | -39.82M | -36.7M | 90.83M | -51.77M | -19.13M | -2.31M | -55.71M |
| Depreciation & Amortization | 236K | 223K | 223K | 355K | 476K | 273K | 280K | 194K | 62K | 62K | 502K | 516K |
| Stock-Based Compensation | 0 | 2.27M | 760K | 748K | 519K | 2.22M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.82M | 386K | 1.62M | -1.05M | -10.37M | 3.14M | 4.04M | -122.35M | 16.02M | -3.32M | -22.57M | 32.23M |
| Working Capital Changes | -2.41M | 5.52M | -606K | -4.21M | -3.28M | 1.2M | -1.66M | 1.05M | 2.09M | -5.36M | 3.54M | 1.55M |
| Change in Receivables | -541K | 318K | 254K | -636K | 561K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -158K | -399K | -910K | -81K | -272K | -372K | -1.61M | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -624K | 642K | -2.65M | -3.44M | 2.48M | 78K | 580K | -948K | 4K | 808K | 3.24M | -1.1M |
| Cash from Investing | 19.25M | 16.85M | -28.67M | 23.11M | -3.14M | -8.62M | -15.93M | 96.86M | -5.32M | -4.83M | -5.16M | -4.88M |
| Capital Expenditures | 0 | 0 | 0 | 0 | -3M | -41K | -92K | -134K | -59K | -35K | -8K | -8K |
| CapEx % of Revenue | 723.74% | - | - | - | 10.41% | 2.86% | 16.43% | 23.8% | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 98M | 0 | 0 | 0 | 0 |
| Cash from Financing | 2K | 146.09M | 86.91M | 5.63M | 0 | 135K | 0 | 20.16M | 0 | 97K | 21.2M | 69.34M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20M | 0 | 0 | 21.74M | 0 |
| Equity Issued (Net) | 0 | 145.99M | 86.95M | 5.63M | 0 | -159K | 0 | 159K | 0 | 97K | -531K | 69.34M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 443K |
| Other Financing | 2K | 98K | -46K | 0 | 0 | 294K | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -944K | 147.42M | 30.41M | -1.04M | -15.43M | -41.73M | -49.81M | 86.72M | -38.97M | -32.36M | -4.85M | 43.02M |
| Free Cash Flow | 0 | -15.53M | -27.82M | -29.9M | -12.37M | -33.04M | -34.12M | -30.41M | -33.66M | -27.78M | -20.84M | -21.43M |
| FCF Margin % | - | -604.63% | -1576.32% | -1515.51% | -42.93% | -2303.77% | -6093.57% | -5401.6% | - | - | - | - |
| FCF Growth % | 100% | 53% | 18.47% | 1.68% | 63.25% | -18.91% | -63.77% | -41.89% | -26.9% | -45.25% | -7.87% | -15.78% |
| FCF per Share | - | -0.14 | -0.64 | -4.03 | -1.80 | -4.88 | -5.10 | -4.54 | -5.05 | -4.19 | -3.17 | -3.81 |
| FCF Conversion (FCF/Net Income) | 0.97x | 0.65x | 0.93x | 1.16x | -43.86x | 0.83x | 0.93x | -0.33x | 0.65x | 1.45x | 9.04x | 0.38x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |